Table 3.
B | OR (95% C.I.) | p | |
---|---|---|---|
Sex* | 0.030 | 1.030 (0.611–1.739) | 0.911 |
Age# | 0.035 | 1.035 (0.886–1.210) | 0.661 |
Duration of pain (years) | 0.052 | 1.054 (0.995–1.116) | 0.074 |
Tenosynovitis | |||
2P-BS | 3.610 | 36.981 (11.268–121.373) | < 0.001 |
P/Ex | 0.977 | 2.657 (1.639–4.306) | < 0.001 |
RF† | 1.694 | 5.439 (4.023–7.353) | < 0.001 |
ACPA† | 2.436 | 11.423 (7.770–16.795) | < 0.001 |
CRP‡ | 1.832 | 6.244 (3.648–10.689) | < 0.001 |
ESR‡ | 1.802 | 6.064 (3.854–9.541) | < 0.001 |
RA rheumatoid arthritis, OR Odds ratio, C.I. confidence interval, 2P-BS two-phase bone scintigraphy, P/Ex physical examination, RF rheumatoid factor, ACPA anti-cyclic citrullinated protein antibody, CRP C-reactive protein, ESR estimated sedimentation rate
*Sex was divided into male and female
#Age was grouped into intervals of 10 years
†RF and ACPA were divided into negative with their normal references (≤ 15 IU/mL and < 25 U/mL, respectively), low-positive (higher than the upper normal reference but ≤ 3 times), and high-positive (> 3 times the upper normal reference)
‡CRP and ESR were into normal when their values were within their normal ranges (≤ 0.8 mg/dL and 20 mm/h respectively). Higher values than the normal ranges were defined as abnormal